AMGN vs AZZ · P/E 24, rev $36.75B vs P/E 14, rev $1.58B
Amgen Inc (AMGN) versus AZZ Incorporated (AZZ) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
AZZ Incorporated (AZZ) is a specialty business services company listed on NYSE.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported AZZ revenue for 2025-02-28 was $1.58B. Net income was $128.8M. Revenue was up 2.6% from 2024-02-29 to 2025-02-28. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
Not investment advice. Open the AMGN and AZZ stock pages for the full models.
Not investment advice.